Vivani Medical, Inc. (VANI) Stock Analysis & Investment Frameworks
Vivani Medical, Inc. (VANI) stock analysis on Invetso. Review Vivani Medical, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Vivani Medical, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
Vivani Medical, Inc. Key Financial Metrics
- Market Cap: $104.64M
- Revenue: $N/A
- ROE: -191.05%
- ROIC: -73.94%
- Dividend Yield: N/A
About Vivani Medical, Inc.
Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases. Its pipeline includes NPM-139 for chronic weight management in patients who are obese or overweight; NPM-133 a semaglutide implant for the treatment of patients with type 2 diabetes; NPM-115, an exenatide implant candidate for chronic weight management in patients who are obese or overweight; and OKV-119, an exenatide implant for the treatment of obesity and diabetes in companion animals, including cats and dogs. The company is headquartered in Alameda, California.
Vivani Medical, Inc. Investment Frameworks
Invetso analyzes Vivani Medical, Inc. (VANI) across the following frameworks:
- Vivani Medical, Inc. 10Y Growth Potential
- Vivani Medical, Inc. Scenario Analysis
- Vivani Medical, Inc. Risks & Opportunities
- Vivani Medical, Inc. Economic Moat
- Vivani Medical, Inc. Business Model
- Vivani Medical, Inc. Management
- Vivani Medical, Inc. SWOT Analysis
- Vivani Medical, Inc. Porter's 5 Forces
- Vivani Medical, Inc. PESTLE Analysis
- Vivani Medical, Inc. ESG Analysis